Quote | Agenus Inc. (NASDAQ:AGEN)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | Agenus Inc. (NASDAQ:AGEN)
2023-06-05 11:38:01 ET Summary Agenus Inc. has existed for a long three decades, doing nothing much really. They have been producing very strong data from botensilimab lately. Agenus Inc. prospects could now change for the better. My beef against Agenus Inc. ( ...
AGEN2373 is the first CD137 agonist antibody reporting single agent responses with no major toxicity Responses reported in patients with prostate cancer, ampullary carcinoma and metastatic vulvar squamous cell carcinoma No hepatic toxicities, grade ≥3 treatment-related adverse even...
Message Board Posts | Agenus Inc. (NASDAQ:AGEN)
|whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI||whytestocks||investorshangout||05/03/2023 6:35:51 PM|
|shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma||shalbyj||investorshangout||04/25/2023 1:37:15 PM|
|whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti||whytestocks||investorshangout||04/17/2023 12:00:59 PM|
|whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur||whytestocks||investorshangout||03/27/2023 3:10:50 PM|
|whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week||whytestocks||investorshangout||03/15/2023 8:20:47 PM|
Agenus Inc. Company Name:
AGEN Stock Symbol:
Agenus Inc. Website:
News, Short Squeeze, Breakout and More Instantly...